Technical Analysis for TBIO - Telesis Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.33 | 7.29% | 0.02 |
Earnings due: May 10
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 7.29% | |
| Volume Surge | Other | 7.29% | |
| New 52 Week Low | Weakness | 7.29% | |
| Stochastic Reached Oversold | Weakness | 7.29% | |
| Wide Bands | Range Expansion | 7.29% | |
| Gapped Down | Weakness | 7.29% | |
| Oversold Stochastic | Weakness | 7.29% | |
| Narrow Range Bar | Range Contraction | -3.41% | |
| Inside Day | Range Contraction | -3.41% | |
| Wide Bands | Range Expansion | -3.41% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 3 hours ago |
| 10 DMA Resistance | about 3 hours ago |
| 10x Volume Pace | about 3 hours ago |
| Down 1% | about 3 hours ago |
| Possible Pocket Pivot | about 3 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/10/2024
Telesis Bio, Inc. Description
Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology Gene Expression Synthetic Biology Molecular Genetics Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.99 |
| 52 Week Low | 0.28 |
| Average Volume | 135,961 |
| 200-Day Moving Average | 0.69 |
| 50-Day Moving Average | 0.44 |
| 20-Day Moving Average | 0.35 |
| 10-Day Moving Average | 0.33 |
| Average True Range | 0.05 |
| RSI (14) | 35.48 |
| ADX | 12.28 |
| +DI | 15.58 |
| -DI | 20.28 |
| Chandelier Exit (Long, 3 ATRs) | 0.33 |
| Chandelier Exit (Short, 3 ATRs) | 0.42 |
| Upper Bollinger Bands | 0.43 |
| Lower Bollinger Band | 0.28 |
| Percent B (%b) | 0.2 |
| BandWidth | 42.71 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.03 |
| MACD Histogram | 0.002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.37 | ||||
| Resistance 3 (R3) | 0.36 | 0.34 | 0.36 | ||
| Resistance 2 (R2) | 0.34 | 0.33 | 0.34 | 0.35 | |
| Resistance 1 (R1) | 0.32 | 0.32 | 0.31 | 0.33 | 0.35 |
| Pivot Point | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
| Support 1 (S1) | 0.28 | 0.29 | 0.27 | 0.29 | 0.26 |
| Support 2 (S2) | 0.26 | 0.28 | 0.26 | 0.26 | |
| Support 3 (S3) | 0.24 | 0.26 | 0.26 | ||
| Support 4 (S4) | 0.25 |
